169 related articles for article (PubMed ID: 16194869)
1. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A
Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869
[TBL] [Abstract][Full Text] [Related]
2. Micro-imaging of amyloid in mice.
Wall JS; Paulus MJ; Gleason S; Gregor J; Solomon A; Kennel SJ
Methods Enzymol; 2006; 412():161-82. PubMed ID: 17046658
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.
Wall JS; Richey T; Williams A; Stuckey A; Osborne D; Martin E; Kennel SJ
Mol Imaging Biol; 2012 Aug; 14(4):402-7. PubMed ID: 22042488
[TBL] [Abstract][Full Text] [Related]
4. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A
J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.
Kennel SJ; Stuckey A; McWilliams-Koeppen HP; Richey T; Wall JS
Mol Imaging Biol; 2016 Aug; 18(4):483-9. PubMed ID: 26573301
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
Martin EB; Williams A; Richey T; Stuckey A; Heidel RE; Kennel SJ; Wall JS
Sci Rep; 2016 Mar; 6():22695. PubMed ID: 26936002
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and monitoring of amyloidosis.
Hawkins PN
Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
[TBL] [Abstract][Full Text] [Related]
9. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse model of AA amyloidosis.
Solomon A; Weiss DT; Schell M; Hrncic R; Murphy CL; Wall J; McGavin MD; Pan HJ; Kabalka GW; Paulus MJ
Am J Pathol; 1999 Apr; 154(4):1267-72. PubMed ID: 10233864
[TBL] [Abstract][Full Text] [Related]
11. Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.
Wall JS; Richey T; Allen A; Donnell R; Kennel SJ; Solomon A
Comp Med; 2008 Dec; 58(6):542-50. PubMed ID: 19149411
[TBL] [Abstract][Full Text] [Related]
12. Discrete binding patterns of two heparin-reactive proteins, basic fibroblast growth factor and peptide p5R, in amyloid-laden and healthy mice.
Martin EB; Donnell R; Richey T; Stuckey A; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2021 May; 552():136-141. PubMed ID: 33744761
[TBL] [Abstract][Full Text] [Related]
13. Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants.
Wall JS; Williams A; Richey T; Stuckey A; Wooliver C; Christopher Scott J; Donnell R; Martin EB; Kennel SJ
Mol Imaging Biol; 2017 Oct; 19(5):714-722. PubMed ID: 28229334
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
Hawkins PN; Lavender JP; Pepys MB
N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
[TBL] [Abstract][Full Text] [Related]
15. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.
Wall JS; Richey T; Stuckey A; Donnell R; Macy S; Martin EB; Williams A; Higuchi K; Kennel SJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E586-94. PubMed ID: 21807994
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
[TBL] [Abstract][Full Text] [Related]
17. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.
Wall JS; Martin EB; Richey T; Stuckey AC; Macy S; Wooliver C; Williams A; Foster JS; McWilliams-Koeppen P; Uberbacher E; Cheng X; Kennel SJ
Molecules; 2015 Apr; 20(5):7657-82. PubMed ID: 25923515
[TBL] [Abstract][Full Text] [Related]
19. SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.
Wall JS; Richey T; Stuckey A; Donnell R; Oosterhof A; van Kuppevelt TH; Smits NC; Kennel SJ
Nucl Med Biol; 2012 Jan; 39(1):65-75. PubMed ID: 21958847
[TBL] [Abstract][Full Text] [Related]
20. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
Inoue S; Kawano H; Ishihara T; Maeda S; Ohno S
Amyloid; 2005 Sep; 12(3):157-63. PubMed ID: 16194870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
